TADLIQ
NDC 46287-045, Tadalafil, suspension, from CMP Pharma, Inc..
- Product NDC
- 46287-045
- Status
- Listed
- Labeler
- CMP Pharma, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214522
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/46287-045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TADALAFIL20 mg/5mL
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 46287-045-15 | 46287004515 | 150 mL in 1 BOTTLE (46287-045-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7a909b25-3772-403e-a5fe-e4a040293fb7NADAC price for package 46287004515
GET /v1/drugs/nadac/46287004515
Use it
Look up 46287-045 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/46287-045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 46287-045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.